| Friday, July 11 |
Session Moderators: Richard Kloos & Ernest Mazzaferri |
Faculty |
Faculty |
Session Chair |
| 7:45 am |
Welcome and ATA Guideline Comments |
David Cooper |
|
|
8:00 am –
8:30 am |
Changing Demographics in Thyroid Cancer: Impact on Management |
Ernest Mazzaferri |
|
|
8:30 am –
9:00 am |
Thyroid Nodules: Diagnostic & Therapeutic Dilemmas |
Hossein Gharib |
|
|
9:00 am –
9:30 am |
Preoperative & Initial Surgical Management of DTC: Extent of Thyroid and Lymph node Surgery |
Gerard Doherty |
|
|
| 9:30 am – 10:00 am |
Postoperative I-131 Remnant Ablation & therapy: Risk & Benefits, I-131 Dosimetry vs. Empiric Therapy |
Bryan Haugen |
|
|
| 10:00 am – 10:30 am |
BREAK (outside main meeting room) |
|
|
|
| 10:30 am – 11:00 am |
New Paradigms and Problems in the Follow-up of DTC: US, Tg, and imaging |
Martin Schlumberger |
|
|
| 11:00 am – 12:00 noon |
Panel Discussion Case Initial Management Low and high Risk Tumors |
Gerard Doherty; Stephanie Lee |
Ernest Mazzaferri |
David Cooper |
| 12:00 noon – 1:00 pm |
Meet the Professor Sessions based on Case Studies with LUNCH |
|
|
|
| |
MTP1: Neck US for Thyroid Nodules, DTC, & Lymph Node Metastases |
Susan Mandel |
|
|
| |
MTP2: DTC & MTC Molecular-Based therapy and clinical trials |
Matthew Ringel |
|
|
| |
MTP3: Management of DTC Distant Metastases |
R. Mike Tuttle |
|
|
| |
MTP4: TSH Suppression During DTC Follow-up |
David Cooper |
|
|
| |
MTP5: Management of Low Risk DTC Patients |
Stephanie Lee |
|
|
1:00 pm –
2:00 pm |
Debate: Which thyroid Nodules Should Undergo FNA |
Susan Mandel |
Bryan Haugen |
Richard Kloos |
2:00 pm –
3:00 pm |
Debate: Prophylactic Central Neck Dissection in PTC |
Gerard Doherty |
David Steward |
Ernest Mazzaferri |
3:00 pm –
3:30 pm |
BREAK (in the Exhibit Hall) |
|
|
|
3:30 pm –
4:30 pm |
Debate: Radioiodine Ablation for Low Risk PTC |
Ernest Mazzaferri |
R. Mike Tuttle |
Matthew Ringel |
4:30 pm –
5:30 pm |
Panel Discussion Case Management Distant Metastases |
Jeffrey Moley; Martin Schlumberger |
Matthew Ringel |
Steven Sherman |
5:30 pm –
6:00 pm |
Questions & Answers |
Bryan Haugen |
|
|
| 6:00 pm |
Adjourn |
|
|
|
| Saturday, July 12 |
Session Moderators: Richard Kloos & Ernest Mazzaferri |
Faculty |
Faculty |
Session Chair |
| 7:45 am |
Welcome and ATA Guideline Comments |
Richard Kloos |
|
|
8:00 am –
8:30 am |
Anaplastic Thyroid Cancer |
Steven Sherman |
|
|
8:30 am –
9:30 am |
Panel: Observation vs Resection of Persistent DTC lymph Node Metastases |
Jeffrey Moley; Martin Schlumberger |
Douglas Evans; Hossein Gharib |
David Steward |
9:30 am –
10:00 am |
Special Problems: Managing DTC during Pregnancy and in the Elderly Patients. |
Steven Sherman |
|
|
10:00 am –
10:30 am |
BREAK (in the Exhibit Hall) |
|
|
|
10:30 am –
11:30 am |
Panel: High Serum Tg levels and Negative Whole Body Scans |
David Steward; Hossein Gharib |
Ernest Mazzaferri |
Bryan Haugen |
11:30 am –
12:00 Noon |
When to stop treating with radioiodine |
R. Mike Tuttle |
|
|
| 12:00 noon – 1:00 pm |
Meet the Professor Sessions based on Case Studies with LUNCH |
|
|
|
| |
MTP1: Neck US for thyroid Nodules, DTC, & Lymph Node Metastases |
Susan Mandel |
|
|
| |
MTP2: DTC & MTC Molecular-Based Therapy and Clinical Trials |
Steven Sherman |
|
|
| |
MTP3: Management of DTC Distant Metastases |
R. Mike Tuttle |
|
|
| |
MTP4: TSH Suppression During DTC Follow-up |
David Cooper |
|
|
| |
MTP5: Management of Low Risk DTC Patients |
Stephanie Lee |
|
|
1:00 pm –
1:30 pm |
MTC Genotype-Phenotype Correlations and Their Natural History |
Richard Kloos |
|
|
1:30 pm –
2:00 pm |
Prophylactic Surgery for Medullary Thyroid Cancer: Timing & Outcome |
Douglas Evans |
|
|
2:00 pm –
2:30 pm |
Therapeutic Surgery for MTC: pre-operative evaluation and extent of surgery |
Jeffrey Moley |
|
|
2:30 pm –
3:00 pm |
Persistent & Recurrent MTC: Evaluation and Clinical Decision Making |
Martin Schlumberger |
|
|
3:00 pm –
3:30 pm |
BREAK (in the Exhibit Hall) |
|
|
|
3:30 pm -
4:00 pm |
Targeting MTC for Molecular-Based Therapy: An Overview of Phase I and II Trials |
Samuel Wells |
|
|
4:00 pm –
4:30 pm |
MEN 2 Associated Pheochromocytoma and Hyperparathyroidism |
Douglas Evans |
|
|
4:30 pm –
5:30 pm |
Panel Discussion Case Management of MTC |
Samuel Wells; Hossein Gharib |
Douglas Evans |
Richard Kloos |
5:30 pm –
6:00 pm |
Questions & Answers |
Samuel Wells |
|
|
| 6:00 pm |
Adjourn |
|
|
|
Print page
Email page
